In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes.
Adolescent
Adult
Aged
CA1 Region, Hippocampal
/ metabolism
CA3 Region, Hippocampal
Epilepsy, Temporal Lobe
/ diagnostic imaging
Female
Fluorodeoxyglucose F18
Glutamic Acid
/ genetics
Hippocampus
/ metabolism
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neurosurgical Procedures
Oximes
Positron-Emission Tomography
Pyridines
Radiopharmaceuticals
Receptors, Kainic Acid
/ genetics
Treatment Outcome
Young Adult
glutamate
glutamate receptors
mesial temporal lobe epilepsy
neuroimaging
positron emission tomography
postoperative outcome
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
11
05
2021
received:
28
01
2021
accepted:
12
05
2021
pubmed:
2
6
2021
medline:
16
10
2021
entrez:
1
6
2021
Statut:
ppublish
Résumé
Previous positron emission tomography (PET) studies using [ We obtained magnetic resonance imaging (MRI) and [ MTLE [ Reduced mGluR5 allosteric site availability in hippocampal CA1-3, measured in vivo by [
Substances chimiques
3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloxime
0
Gluk1 kainate receptor
0
Oximes
0
Pyridines
0
Radiopharmaceuticals
0
Receptors, Kainic Acid
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Glutamic Acid
3KX376GY7L
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1559-1568Subventions
Organisme : CIHR
ID : MOP-115131
Pays : Canada
Organisme : CIHR
ID : MOP-93614
Pays : Canada
Informations de copyright
© 2021 International League Against Epilepsy.
Références
Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci. 1996;8(7):1488-500.
Riedel G, Reymann KG. Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory. Acta Physiol Scand. 1996;157(1):1-19.
Watabe AM, Carlisle HJ, O'Dell TJ. Postsynaptic induction and presynaptic expression of group 1 mGluR-dependent LTD in the hippocampal CA1 region. J Neurophysiol. 2002;87(3):1395-403.
Merlin LR. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol. 2002;87(1):621-5.
Choi H, Kim YK, Oh SW, Im H-J, Hwang DW, Kang H, et al. In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model. PLoS One. 2014;9(3):e92765.
Bascuñana P, Gendron T, Sander K, Jahreis I, Polyak A, Ross TL, et al. Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers. Epilepsia. 2019;60(11):2325-33.
Ure J, Baudry M, Perassolo M. Metabotropic glutamate receptors and epilepsy. J Neurol Sci. 2006;247(1):1-9.
Krystal JH. Imaging the glutamate synapse. Nat Med. 2020;26(2):165-7.
Ametamey SM, Treyer V, Streffer J, Wyss MT, Schmidt M, Blagoev M, et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med. 2007;48(2):247-52.
Dubois JM, Rousset OG, Guiot MC, Hall JA, Reader AJ, Soucy JP, et al. Metabotropic glutamate receptor type 5 (mGluR5) cortical abnormalities in focal cortical dysplasia identified in vivo with [11C]ABP688 positron-emission tomography (PET) imaging. Cereb Cortex. 2016;26(11):4170-9.
Lam J, DuBois JM, Rowley J, González-Otárula KA, Soucy JP, Massarweh G, et al. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy. Ann Neurol. 2019;85(2):218-28.
Chugani DC, Ackermann RF, Phelps ME. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab. 1988;8(3):291-303.
Zimmer E, Parent MJ, Leuzy A, Aliaga A, Aliaga A, Moquin L, et al. Imaging in vivo glutamate fluctuations with [11C]ABP688: a GLT-1 challenge with ceftriaxone. J Cereb Blood Flow Metab. 2014;2015:1-6.
Tang FR, Lee WL, Yeo TT. Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol. 2001;30(5):403-11.
Notenboom RGE, Hampson DR, Jansen GH, van Rijen PC, van Veelen CWM, van Nieuwenhuizen O, et al. Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain. 2006;129(Pt 1):96-107.
Kandratavicius L, Rosa-Neto P, Monteiro MR, Guiot MC, Assirati JA, Carlotti CG, et al. Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis. Hippocampus. 2013;23(12):1212-30.
Eid T, Thomas M, Spencer D, Rundén-Pran E, Lai J, Malthankar G, et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet. 2004;363(9402):28-37.
de Lanerolle NC, Lee TS. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav. 2005;7(2):190-203.
Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong STC, Matson GB, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 1997;42(6):829-37.
DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, et al. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET. Eur J Nucl Med Mol Imaging. 2016;43(1):152-62.
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512-21.
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I. Segmentation and surface reconstruction. Neuroimage. 1999;9(2):179-94.
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341-55.
Iglesias JE, Augustinack JC, Nguyen K, Player CM, Player A, Wright M, et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. Neuroimage. 2015;115:117-37.
Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39(5):904-11.
Thomas BA, Erlandsson K, Modat M, Thurfjell L, Vandenberghe R, Ourselin S, et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2011;38(6):1104-19.
Elmenhorst D, Minuzzi L, Aliaga A, Rowley J, Massarweh G, Diksic M, et al. In vivo and in vitro validation of reference tissue models for the mGluR5 ligand [11C]ABP688. J Cereb Blood Flow Metab. 2010;30(8):1538-49.
Santyr BG, Goubran M, Lau JC, Kwan BYM, Salehi F, Lee DH, et al. Investigation of hippocampal substructures in focal temporal lobe epilepsy with and without hippocampal sclerosis at 7T. J Magn Reson Imaging. 2017;45(5):1359-70.
Kreilkamp BAK, Weber B, Elkommos SB, Richardson MP, Keller SS. Hippocampal subfield segmentation in temporal lobe epilepsy: relation to outcomes. Acta Neurol Scand. 2018;137(6):598-608.
Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim H-I, et al. [18F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017;20(3):393-5.
Changeux J, Edelstein S. Allosteric mechanisms of signal transduction. Science. 2005;308(5727):1424-8.
During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet. 1993;341(8861):1607-10.
Miyake N, Skinbjerg M, Easwaramoorthy B, Kumar D, Girgis RR, Xu X, et al. Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11 C] ABP688 and N-acetylcysteine challenge. Biol Psychiatry. 2011;69:822-4.
Sandiego CM, Nabulsi N, Lin SF, Labaree D, Najafzadeh S, Huang Y, et al. Studies of the metabotropic glutamate receptor 5 radioligand [11C]ABP688 with N-acetylcysteine challenge in rhesus monkeys. Synapse. 2013;67(8):489-501.
Delorenzo C, Dellagioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, et al. In vivo ketamine-induced changes in [11C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biol Psychiatry. 2015;77(3):266-75.
Cavus I, Kasoff WS, Cassaday MP, Jacob R, Gueorguieva R, Sherwin RS, et al. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol. 2005;57(2):226-35.
Nag S, Varnäs K, Arakawa R, Jahan M, Schou M, Farde L, et al. Synthesis, biodistribution, and radiation dosimetry of a novel mGluR5 radioligand: 18F-AZD9272. ACS Chem Neurosci. 2020;11(7):1048-57.
Kuwabara H, Chamroonrat W, Mathews W, Waterhouse R, Brasic J, Guevara MR, et al. Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain. J Nucl Med. 2011;52(Suppl 1):390.
Wanger-Baumann CA, Mu L, Honer M, Belli S, Alf MF, Schubiger PA, et al. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). Neuroimage. 2011;56(3):984-91.
DeLorenzo C, Gallezot JD, Gardus J, Yang J, Planeta B, Nabulsi N, et al. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB. J Cereb Blood Flow Metab. 2017;37(8):2716-27.